| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |